Role of Circulating Tumor DNA in Gastrointestinal Cancers: Update From Abstracts and Sessions at ASCO 2018
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Circulating Tumor DNA in Gastrointestinal Cancers: Update From Abstracts and Sessions at ASCO 2018
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-08
DOI
10.3389/fonc.2019.00358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
- (2018) Jason D. Merker et al. JOURNAL OF CLINICAL ONCOLOGY
- Margetuximab (M) plus pembrolizumab (P) in ERBB2-amplified PD-L1+ gastroesophageal adenocarcinoma (GEA) post trastuzumab (T).
- (2018) Daniel V.T. Catenacci et al. JOURNAL OF CLINICAL ONCOLOGY
- Feasibility and clinical value of circulating tumor DNA testing in patients with gastroesophageal adenocarcinoma.
- (2018) Madiha Iqbal et al. JOURNAL OF CLINICAL ONCOLOGY
- The mutational landscape of circulating cell free DNA in patients with esophageal squamous cell carcinoma response and non-response to neoadjuvant chemotherapy.
- (2018) Ruixiang Zhang et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of circulating tumor DNA and clinical correlates in patients with esophageal, gastroesophageal junction and gastric adenocarcinoma.
- (2018) Ryosuke Okamura et al. JOURNAL OF CLINICAL ONCOLOGY
- Postradiation ctDNA status as a prognostic factor in locally advanced esophageal squamous cell carcinoma.
- (2018) Ru Jia et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of early recurrence in HCC patients after TACE treatment with plasma cfDNA.
- (2018) Xiao Du et al. JOURNAL OF CLINICAL ONCOLOGY
- Monitoring circulating tumor DNA revealed dynamic changes in KRAS status in patients with metastatic colorectal cancer.
- (2018) Yuji Takayama et al. JOURNAL OF CLINICAL ONCOLOGY
- Apatinib as a salvage treatment for refractory metastatic colorectal cancer.
- (2018) Xiaofeng Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of circulating tumor DNA to monitor disease status in colorectal cancer after surgery.
- (2018) Liren Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-EGFR resistant clones decay exponentially after progression: Implications for anti-EGFR rechallenge.
- (2018) Christine Megerdichian Parseghian et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of ctDNA biomarkers post resection and relationship to recurrent disease in colorectal cancer patients.
- (2018) David Murray et al. JOURNAL OF CLINICAL ONCOLOGY
- High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib.
- (2018) Pashalina Kehagias et al. JOURNAL OF CLINICAL ONCOLOGY
- REVERCE: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan—Biomarker analysis.
- (2018) Yasushi Tsuji et al. JOURNAL OF CLINICAL ONCOLOGY
- Actionable fusions in colorectal cancer using a cell-free circulating tumor DNA (ctDNA) assay.
- (2018) Katherine Clifton et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumor DNA (ctDNA) as an early marker to monitor clinical benefit of regorafenib and TAS-102 in patients with metastatic colorectal cancer (mCRC).
- (2018) Allan Andresson Lima Pereira et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal canal carcinoma.
- (2018) Luc Cabel et al. JOURNAL OF CLINICAL ONCOLOGY
- Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC).
- (2018) Jeanne Tie et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I/II trial of cabozantinib (C) with or without panitumumab (P) in patients (pts) with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Clinical outcomes in pts with MET amplification (amp) detected in blood.
- (2018) Jingquan Jia et al. JOURNAL OF CLINICAL ONCOLOGY
- Plasma HER2 (ERBB2) copy number to predict response to HER2-targeted therapy in metastatic colorectal cancer.
- (2018) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Predicting treatment outcome of rectal cancer patients underwent neoadjuvant chemoradiotherapy by ctDNA: The potential use of ctDNA monitoring as organ-sparing approach.
- (2018) Lifeng Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- A prospective cohort study in colorectal cancer assessing the relationship between post-surgery detection of methylated BCAT1 or IKZF1 ctDNA and risk for residual disease and survival.
- (2018) David Murray et al. JOURNAL OF CLINICAL ONCOLOGY
- Concordance in RAS mutation status between liquid and solid biopsies in subjects with RAS wild-type (wt) metastatic colorectal cancer (mCRC) in first-line treatment in Spain: PERSEIDA study (NCT02792478).
- (2018) Manuel Valladares-Ayerbes et al. JOURNAL OF CLINICAL ONCOLOGY
- Serial analysis of mutant KRAS in circulation cell-free DNA (cfDNA) of patients with KRAS mutant metastatic colorectal cancer: A translational study of the KRK0207 trial.
- (2018) Jens T Siveke et al. JOURNAL OF CLINICAL ONCOLOGY
- The mutational landscape of circulating cell free DNA in patients with colorectal adenoma and carcinoma.
- (2018) Ying Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumor DNA dynamics in resectable gastric cancer.
- (2018) Alessandro Leal et al. JOURNAL OF CLINICAL ONCOLOGY
- Real-time circulating tumor DNA profiling of advanced cholangiocarcinoma (CCA).
- (2018) Kabir Mody et al. JOURNAL OF CLINICAL ONCOLOGY
- Genotyping of circulating tumor DNA in biliary tract cancer reveals diagnostic and prognostic information.
- (2018) Andreas Wolfgang Berger et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumor DNA as a prognostic biomarker in early stage pancreatic cancer.
- (2018) Belinda Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumor DNA profiling to identify patients with metastatic colorectal cancer with improved overall survival following Sym004 treatment.
- (2018) Thomas Tuxen Poulsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Dynamic monitoring of driver gene mutation profiles in plasma cfDNA using an 85 gene panel for postoperative prognosis in colorectal cancer.
- (2018) Tanxiao Huang et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of tumor location and variables associated with overall survival in patients with colorectal cancer.
- (2018) Cassia B Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation of measurements of tumor heterogeneity based on next-generation sequencing (NGS) of circulating tumor DNA (ctDNA) with clinical outcomes in STEAM, a prospective, randomized, multicenter study in metastatic colorectal cancer (mCRC).
- (2018) Stephanie Yaung et al. JOURNAL OF CLINICAL ONCOLOGY
- ctDNA sequencing for early detection of colorectal cancers: Comparative analysis of colon cancer and rectal cancer data.
- (2018) Xiaoni Zhang et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarker study for trastuzumab continuation beyond progression in a randomized phase II trial of weekly paclitaxel±trastuzumab in patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum (WJOG7112G).
- (2018) Yasutaka Sukawa et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now